Pentazocine inhibits norepinephrine transporter function by reducing its surface expression in bovine adrenal medullary cells

Journal of Pharmacological Sciences

Volumn 121, Issue 2, 2013, Pages 138-147

  Obara, Go ^a   Toyohira, Yumiko ^a   Inagaki, Hirohide ^a   Takahashi, Keita ^a   Horishita, Takafumi ^a   Kawasaki, Takashi ^a   Ueno, Susumu ^b   Tsutsui, Masato ^c   Sata, Takeyoshi ^a   Yanagihara, Nobuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Adrenal medullary cell; Descending noradrenergic inhibitory system; Norepinephrine transporter; Pentazocine; SK N SH cell

Indexed keywords

BINALTORPHIMINE; KAPPA OPIATE RECEPTOR ANTAGONIST; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; NISOXETINE; NORADRENALIN TRANSPORTER; OPIATE ANTAGONIST; OPIATE RECEPTOR; PENTAZOCINE; SIGMA OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADRENAL MEDULLA; ADRENAL MEDULLA CELL; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL MEMBRANE; CELL SURFACE; CHEMICAL PARAMETERS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; EADIE HOFSTEE ANALYSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KINETICS; MAXIMAL BINDING; MAXIMAL VELOCITY; MICHAELIS CONSTANT; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCATCHARD PLOT; WESTERN BLOTTING;

EID: 84874158087     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12164FP     Document Type: Article

References (37)

1. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, Goodman-Gilman A, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 569-619.
2. McQuay HJ. Pharmacological treatment of neuralgic and neuropathic pain. Cancer Surv. 1988;7:141-159.
3. Sharav Y, Singer E, Schmidt E, Dionne RA, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain. 1987;31:199-209.
4. Magni G. The use of antidepressants in the treatment of chronic pain. A review of the current evidence. Drugs. 1991;42: 730-748. (Pubitemid 21920781)
5. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256.
6. Larson AA, Takemori AE. Effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake, on morphine analgesia and the development of tolerance. Life Sci. 1977;21:1807-1811. (Pubitemid 8268321)
7. Malseed RT, Goldstein FJ. Enhancement of morphine analgesia by tricyclic antidepressants. Neuropharmacology. 1979;18:827-829. (Pubitemid 10225287)
8. Ossipov MH, Malseed RT, Goldstein FJ. Augmentation of central and peripheral morphine analgesia by desipramine. Arch Int Pharmacodyn Ther. 1982;259:222-229. (Pubitemid 13244037)
9. Ossipov MH, Harris S, Lloyd P, Messineo E. An isobolographic analysis of the antinociceptive effect of systemically and intra-thecally administered combinations of clonidine and opiates. J Pharmacol Exp Ther. 1990;255:1107-1116.
10. Bergman SA, Wynn RL, Alvarez L, Asher K, Thut PD. Imipra-mine-fentanyl antinociception in a rabbit tooth pulp model. Life Sci. 1991;49:1279-1288.
11. Pacholczyk T, Blakely RD, Amara SG. Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature. 1991;350:350-354. (Pubitemid 21912229)
12. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci. 1993;16:73-93. (Pubitemid 23074001)
13. Bönisch H, Brüss M. The noradrenaline transporter of the neuronal plasma membrane. Ann N Y Acad Sci. 1994;733: 193-202.
14. Baker EL, Blakely RD. Norepinephrine and serotonin transporters. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology. 4th ed. New York: Raven Press; 1995. p. 321-333.
15. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther. 2001;92:21-55. (Pubitemid 34032021)
16. 3H]-desipramine binding site of the bovine adrenomedullary plasma membrane. Naunyn-Schmiedeberg's Arch Pharmacol. 1992;346:203-207.
17. 3H]-noradrenaline by cultured chromaffin cells. Br J Pharmacol. 1984;81:119-123. (Pubitemid 14148323)
18. Lingen B, Brüss M, Bönisch H. Cloning and expression of the bovine sodium-and chloride-dependent noradrenaline transporter. FEBS Lett. 1994;342:235-238. (Pubitemid 24115204)
19. Sagata K, Minami K, Yanagihara N, Shiraishi M, Toyohira Y, Ueno S, et al. Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells. Anesth Analg. 2002;94:901-906. (Pubitemid 34263737)
20. Hara K, Yanagihara N, Minami K, Ueno S, Toyohira Y, Sata T, et al. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedeberg's Arch Pharmacol. 1998;358:328-333. (Pubitemid 28425489)
21. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther. 1992;260:275-285.
22. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol. 1992;105:147-151.
23. Kinouchi K, Maeda S, Saito K, Inoki R, Fukumitsu K, Yoshiya I. Effects of d-and l-pentazocine on the release and uptake of norepinephrine in rat brain cortex. Res Commun Chem Pathol Pharmacol. 1989;63:201-213. (Pubitemid 19070621)
24. 2+ in cultured bovine adrenal medullary cells. J Biol Chem. 1996;271:17463-17468. (Pubitemid 26244312)
25. Toyohira Y, Yanagihara N, Minami K, Ueno S, Uezono Y, Tachikawa E, et al. Down-regulation of the noradrenaline transporter by interferon-α in cultured bovine adrenal medullary cells. J Neurochem. 1998;70:1441-1447. (Pubitemid 28136956)
26. Kippenberger AG, Palmer DJ, Comer AM, Lipski J, Burton LD, Christie DL. Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells. J Neurochem. 1999;73:1024-1032. (Pubitemid 29395458)
27. Morikawa O, Sakai N, Obara H, Saito N. Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol. 1998;349:317-324. (Pubitemid 28277103)
28. Mandela P, Ordway GA. The norepinephrine transporter and its regulation. J Neurochem. 2006;97:310-333.
29. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD. Acute regulation of norepinephrine transport: I. protein ki-nase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther. 1998;287:733-743. (Pubitemid 29133677)
30. Bönisch H, Hammermann R, Brüss M. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter. Adv Pharmacol. 1998;42:183-186.
31. Yeh SY, Todd GD, Johnson RE, Gorodetzky CW, Lange WR. The pharmacokinetics of pentazocine and tripelennamine. Clin Pharmacol Ther. 1986;39:669-676. (Pubitemid 16097307)
32. Pertovaara A. No radrenergic pain modulation. Prog Neurobiol. 2006;80:53-83.
33. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, editors. Textbook of Pain. 4th ed. Edinburgh: Churchill Livingstone; 1999. p. 309-329.
34. 7 receptors. J Pharmacol Sci. 2011;116:388-391.
35. Monks R, Merskey H. Psychotropic drugs. In: Wall PD, Melzack R, editors. Textbook of pain. 4th ed. Edinburgh: Churchill Livingstone; 1999. p. 1155-1186.
36. Hara K, Yanagihara N, Minami K, Hirano H, Sata T, Shigematsu A, et al. Dual effects of intravenous anesthetics on the function of norepinephrine transporters. Anesthesiology. 2000;93:1329-1335.
37. Minami K, Yanagihara N, Segawa K, Tsutsui M, Shigematsu A, Izumi F. Inhibitory effects of propofol on catecholamine secretion and uptake in cultured bovine adrenal medullary cells. Naunyn-Schmiedeberg's Arch Pharmacol. 1996;353:572-578. (Pubitemid 26145168)